13F filer · CIK 1597549
Iguana Healthcare Management, LLC
New York, NY · filing since Q4 2013 · last filing May 15, 2018
Reported value
$152.0M
$-1.5M vs prior
Positions
62
New / sold out
25 / 24
Added / reduced
15 / 14
Turnover
44.0%
buys $67.2M · sells $68.3M
Top-10 weight
38.0%
Biggest buys vs Q4 2017
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | SPDR S&P 500 ETF TRPUT | +50,000 | – | +$13.2M |
| New | SHIRE PLC | +25,000 | – | +$3.7M |
| New | ESPERION THERAPEUTICS INC NEPUT | +50,000 | – | +$3.6M |
| New | CENTENE CORP DEL | +30,000 | – | +$3.2M |
| New | ALEXION PHARMACEUTICALS INC | +27,500 | – | +$3.1M |
| New | LABORATORY CORP AMER HLDGS | +17,500 | – | +$2.8M |
| New | DEXCOM INC | +35,000 | – | +$2.6M |
| New | CATALYST BIOSCIENCES INC | +100,000 | – | +$2.6M |
| New | ZOSANO PHARMA CORP | +500,000 | – | +$2.5M |
| New | ROCKET PHARMACEUTICALS INC | +125,000 | – | +$2.3M |
30 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q4 2017
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | CELGENE CORP | -75,000 | -100.0% | $-7.8M |
| Sold out | AERIE PHARMACEUTICALS INC | -85,000 | -100.0% | $-5.1M |
| Sold out | ABBVIE INC | -50,000 | -100.0% | $-4.8M |
| Reduced | ESPERION THERAPEUTICS INC NE | -65,000 | -39.4% | $-4.7M |
| Reduced | K2M GROUP HLDGS INC | -150,000 | -85.7% | $-2.8M |
| Sold out | JUNO THERAPEUTICS INC | -60,000 | -100.0% | $-2.7M |
| Sold out | ZIMMER BIOMET HLDGS INC | -22,500 | -100.0% | $-2.7M |
| Sold out | INTERSECT ENT INC | -75,000 | -100.0% | $-2.4M |
| Reduced | KARYOPHARM THERAPEUTICS INC | -175,000 | -58.3% | $-2.3M |
| Sold out | DANAHER CORP DEL | -25,000 | -100.0% | $-2.3M |
28 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q1 2018
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TRPUTPUT | 50,000 | $13.2M | 8.66% |
| 2 | ESPERION THERAPEUTICS INC NECOM | 100,000 | $7.2M | 4.76% |
| 3 | IMMUNOMEDICS INCCOM | 400,000 | $5.8M | 3.84% |
| 4 | GLOBAL BLOOD THERAPEUTICS INCOM | 115,000 | $5.6M | 3.65% |
| 5 | HUMANA INCCOM | 20,000 | $5.4M | 3.54% |
| 6 | BIOGEN INCCOM | 17,500 | $4.8M | 3.15% |
| 7 | MERCK & CO INCCOM | 80,000 | $4.4M | 2.87% |
| 8 | ARENA PHARMACEUTICALS INCCOM NEW | 100,000 | $4.0M | 2.60% |
| 9 | SHIRE PLCSPONSORED ADR | 25,000 | $3.7M | 2.46% |
| 10 | CLOVIS ONCOLOGY INCCOM | 70,000 | $3.7M | 2.43% |
52 more rows. Subscribe for $29/month to see every row, download the data and use the API.